HB296
Log in to followAN ACT relating to psychotropic drugs.
Create a new section of KRS Chapter 205 to define terms; require Medicaid-enrolled providers prescribing psychotropic drugs to children to provide an FDA Medication Guide to parents or legal guardians; require medical care providers prescribing psychotropic drugs to children covered by Medicaid to obtain signed informed consent from a parent or guardian; require the Cabinet for Health and Family Services to develop and maintain an adverse drug reaction online reporting system; require the cabinet to compile and submit an annual report of the adverse drug reaction online reporting system to the Legislative Research Commission; require the cabinet to submit an annual report summarizing the implementation efforts and compliance statistics of Medicaid-enrolled providers; establish penalties; require the cabinet to promulgate administrative regulations to implement the system.
Introduced: January 9, 2026
Last action: January 16, 2026
Plain-language summary
This bill would require doctors and other medical providers who prescribe psychotropic drugs to children enrolled in Medicaid to give parents or guardians an FDA Medication Guide and obtain their signed consent before prescribing. It also directs the state Cabinet for Health and Family Services to create an online system for reporting bad drug reactions and to submit yearly reports to the legislature on how the program is working. Providers who do not follow these requirements would face penalties. Who it may affect: parents and legal guardians of children covered by Medicaid, Medicaid-enrolled healthcare providers who prescribe psychotropic medications to minors.
